Get started
Author

Pushpa Pilli

ORCID: 0009-0004-4590-2734
Observed ORCID: 0009-0004-4590-2734
OpenAlex ID: A5006233014
LC-HRMS and NMR studies for the characterization of degradation impurities of ubrogepant along with the in silico approaches for the prediction of degradation and toxicity
2024 · Sowmya Chaganti, Usha Chauhan, et al. · Journal of Pharmaceutical and Biomedical Analysis · 20
In Silico Tools to Thaw the Complexity of the Data: Revolutionizing Drug Research in Drug Metabolism, Pharmacokinetics and Toxicity Prediction
2023 · Hema Sree Kommalapati, Pushpa Pilli, et al. · Current Drug Metabolism · 17
Covalent organic frameworks: spotlight on applications in the pharmaceutical arena
2024 · Pushpa Pilli, Hema Sree Kommalapati, et al. · Bioanalysis · 6
PDF
Green Sample Preparation in Bioanalysis: Where Are We Now?
2023 · Hema Sree Kommalapati, Pushpa Pilli, et al. · Bioanalysis · 5
Separation, Identification, and Characterization of Transformation Products Related to Relugolix Upon Subjecting to In Vitro Gastrointestinal Fluids Utilizing Liquid Chromatography, Mass Spectrometry, and Nuclear Magnetic Resonance Spectroscopy
2024 · Vijaya Madhyanapu Golla, Padakanti Sandeep Chary, et al. · Separation Science Plus · 4
Integrative Study on Triclabendazole Stability: Forced Degradation and In Silico Toxicity Prediction of Degradation Products
2025 · Kavita Pimpre, Sowmya Chaganti, et al. · Biomedical Chromatography · 2
PDF
Separation of Oxidative Degradation Products of the Anti-Cancer Drug Gilteritinib Fumarate by Liquid Chromatography with Photodiode Array and Mass Spectrometric Detection
2025 · Pushpa Pilli, Sowmya Chaganti, et al. · Journal of Analytical Chemistry · 2
Mechanistic enhancement of oral bioavailability through a coamorphous apremilast-aceclofenac systems: integrated LC-MS/MS Bioanalysis, in vivo pharmacokinetics, and PBPK modeling
2026 · Rahul Khemchandani, Ekta Pardhi, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 1
Structural Characterization of Degradation Products Generated From Cenobamate Under Forced Degradation Conditions Using LC–HRMS/MS and NMR
2026 · Pushpa Pilli, Prateek Barik, et al. · Separation Science Plus
LC–HRMS/MS Characterization of Hydrolytic and Photolytic Degradation Pathways of Ripretinib Following Forced Stress Studies
2026 · Vijaya Madhyanapu Golla, Pushpa Pilli, et al. · Rapid Communications in Mass Spectrometry
PDF
Regulatory science-aligned development and multivariate optimisation of a lidocaine-laden novel nanoemulgel for the topical management of imiquimod-induced psoriasis in BALB/c mice
2026 · Ramesh Joga, Ganesh Vambhurkar, et al. · Journal of Drug Delivery Science and Technology
Simultaneous LC–MS/MS Determination of Primary Leachables from Pharma Receptacles: 2-Mercaptobenzothiazole and 1,3-Diphenylguanidine
2026 · Hemasree Kommalapati, Sowmya Chaganti, et al. · Chromatographia
Comprehensive Forced Degradation Study of Pemigatinib and Structural Elucidation of Its Degradation Products Using Liquid Chromatography–High‐Resolution Mass Spectrometry and Nuclear Magnetic Resonance
2026 · Pushpa Pilli, Vijaya Madhyanapu Golla, et al. · Separation Science Plus
Separation and Characterization of Degradation Impurities of Voxelotor by Liquid Chromatography and High Resolution Mass Spectrometry
2026 · Srisailapu V. S. G. B. Prasad, SK. Abdul Rahaman, et al. · Separation Science Plus
PDF
Analytical challenges in the mavacamten impurity analysis: Exploring various cutting edge analytical methods to achieve mass balance for the accurate quantification of analytes
2025 · Vijaya Madhyanapu Golla, Pushpa Pilli, et al. · Journal of the Indian Chemical Society
Works count: 15
Citation count: 57
H-index: 4
I10-index: 2
Year
Topic
Type